<?xml version="1.0" encoding="UTF-8"?>
<p>All patients demonstrated a decrease in the symptom severity during the period of evaluation. However, group A demonstrated an important decrease of 54.5% from the 1
 <sup>st</sup> to 2
 <sup>nd</sup> evaluation, while groups B and C showed a decrease of 40.3% and 28.9% respectively. Group A (n=16) received prednisolone (1%) plus ciprofloxacin (0.3%) demonstrated a trend in improvement of the symptoms when compared to group C (n=16) that received artificial tears plus ciprofloxacin (0.3%) in third evaluation (p=0.055); however, no statistical difference was observed between A and B or between B and C groups in the 1
 <sup>st</sup>, 2
 <sup>nd</sup> 3
 <sup>rd</sup>, 4
 <sup>th</sup> evaluation and in the last assessment respectively ( 
 <xref rid="t2" ref-type="table">Table 2</xref> ).
</p>
